Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41598-017-01644-0 http://scihub22266oqcxt.onion/10.1038/s41598-017-01644-0 C5431951!5431951!28500305     free     free     free Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Sci+Rep 2017 ; 7 (ä): ä Nephropedia Template TP {{tp|p=28500305|t=2017. NSAIDs Use and Reduced Metastasis in Cancer Patients: results from a meta-analysis |pdf=|usr=}}{{28500305}} gab.com Text NSAIDs Use and Reduced Metastasis in Cancer Patients: results from a meta-analysis JO: Sci Rep http://www.kidney.de/pget.php?&tw=1&pmid=28500305 #FOAvip This meta-analysis investigated the relationship between non-steroidal anti-inflammatory drugs (NSAIDs) and lymph node/distant metastasis. Relevant sources were identified from MEDLINE, EMBASE, PubMed, and Cochrane Library. Studies that reported the odds ratio (OR)/risk ratio (RR)/hazard ratio (HR) with 95% confidence intervals (CIs) for the associations of interested outcomes were included. Pooled effect estimates were obtained by using random- or fixed-effect model depending on the heterogeneity across these studies. Sixteen studies involving 202780 participants, including prostate, breast, lung, and colorectal cancer patients, were included. Compared with the reference, generally patients exposed to NSAIDs at pre- and post-diagnosis experienced a significantly reduced risk of distant metastasis (RR 0.708, 95% CI 0.586?0.856 and RR: 0.484, 95% CI: 0.393?0.595, respectively), including prostate cancer (pre-diagnostic use: RR?=?0.874, 95% CI, 0.787?0.97; post-diagnostic use: RR?=?0.482, 95% CI 0.359?0.647), and breast cancer (pre-diagnostic use: RR?=?0.644, 95% CI 0.565?0.735; post-diagnostic use: RR?=?0.485, 95% CI 0.362?0.651). However, lymph node metastasis was weakly related with pre-diagnostic use of NSAIDs (RR?=?0.949, 95% CI 0.914?0.985). NSAIDs are related to a significantly reduced risk of metastasis development, regardless of pre-diagnostic or post-diagnostic use. However, NSAIDs and lymph node metastasis are weakly associated. Our finding suggested a novel metastasis management. Twit Text FOAVip NSAIDs Use and Reduced Metastasis in Cancer Patients: results from a meta-analysis ????Sci Rep http://www.kidney.de/pget.php?&tw=1&pmid=28500305 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28500305 #FOAvip English Wikipedia <ref>{{Cite pmid|28500305}}</ref> NSAIDs Use and Reduced Metastasis in Cancer Patients: results from a meta-analysis #MMPMID28500305 Zhao X; Xu Z; Li H Sci Rep 2017[]; 7 (ä): ä PMID28500305show ga This meta-analysis investigated the relationship between non-steroidal anti-inflammatory drugs (NSAIDs) and lymph node/distant metastasis. Relevant sources were identified from MEDLINE, EMBASE, PubMed, and Cochrane Library. Studies that reported the odds ratio (OR)/risk ratio (RR)/hazard ratio (HR) with 95% confidence intervals (CIs) for the associations of interested outcomes were included. Pooled effect estimates were obtained by using random- or fixed-effect model depending on the heterogeneity across these studies. Sixteen studies involving 202780 participants, including prostate, breast, lung, and colorectal cancer patients, were included. Compared with the reference, generally patients exposed to NSAIDs at pre- and post-diagnosis experienced a significantly reduced risk of distant metastasis (RR 0.708, 95% CI 0.586?0.856 and RR: 0.484, 95% CI: 0.393?0.595, respectively), including prostate cancer (pre-diagnostic use: RR?=?0.874, 95% CI, 0.787?0.97; post-diagnostic use: RR?=?0.482, 95% CI 0.359?0.647), and breast cancer (pre-diagnostic use: RR?=?0.644, 95% CI 0.565?0.735; post-diagnostic use: RR?=?0.485, 95% CI 0.362?0.651). However, lymph node metastasis was weakly related with pre-diagnostic use of NSAIDs (RR?=?0.949, 95% CI 0.914?0.985). NSAIDs are related to a significantly reduced risk of metastasis development, regardless of pre-diagnostic or post-diagnostic use. However, NSAIDs and lymph node metastasis are weakly associated. Our finding suggested a novel metastasis management. äNSAIDs Use and Reduced Metastasis in Cancer Patients: results from a m(epmc).pdf DeepDyve Pubget Overpricing